FAQs on Myeloma Updates from ASCO & EHA 2025
Chris Peña, Director of Education Programs at the Multiple Myeloma Research Foundation, gets updates on the latest multiple myeloma treatment research from Dr. Faith Davies (Director Myeloma Clinical Program, NYU Langone Health; Professor of Medicine, NYU Grossman School of Medicine, New York, New York) and Dr. Omar Nadeem (Clinical Director, Myeloma Immune Effector Cell Therapy Program; Associate Director, Myeloma Clinical Research Program, Dana-Farber Cancer Institute; Instructor of Medicine, Harvard Medical School, Boston, Massachusetts). Dr. Davies and Dr. Nadeem provide updates about the latest myeloma clinical research as presented at the American Society of Clinical Oncology (ASCO) Annual Meeting held May 30, 2025, in Chicago, Illinois, and the European Hematology Association (EHA) 2025 Congress held June 12-15, 2025. Topics will include… 6:46 Newly Diagnosed Multiple Myeloma 21:55 Relapsed/Refractory Multiple Myeloma This session is supported by Adaptive, Alexion, Bristol Myers Squibb, CURE, Genentech, GSK, Kite/Arcellx, Pfizer, Regeneron, and Sanofi. If you have questions, call our MMRF Patient Navigation Center at 1-888-841-6673.
The Modern Myeloma Toolbox | Tarek Mouhieddine, MD #myeloma
FAQs on Multiple Myeloma Highlights From the American Society of Hematology 2025 Annual Meeting
Facebook Live 9/7/22: FAQs on Multiple Myeloma Precursor Conditions
Trump Attends NBA Finals, Cries Election Fraud in California & Storms Out of Interview
THESE Apps Are SPYING on You — Shut Them Off NOW!
FAQs: Navigating First-Line Treatment Options: Induction Therapy, Transplant and Maintenance
Understanding Eco Anxiety in the Workplace A New Challenge for Employers
Something is jamming GPS over Europe. Here's what we found
FAQs: Understanding High-Risk Multiple Myeloma: Beyond Genetics and Key Considerations
CAR T-Cell Therapy at First Relapse
Myeloma Matters Podcast | Transition of Care Part 1: Going From Specialty Center to Community Team
What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service
Relapsed Multiple Myeloma: What Every Patient Needs to Know
Scott Pelley on His Firing and the ‘Massacre’ at ‘60 Minutes’ | The Interview
What are the barriers to research in the community oncology setting?
MGUS- Monoclonal Gammopathy of Undetermined Significance
The Ocean’s Most Misunderstood Predator & Invisible Fences: What Limits Shortfin Mako Movements
FAQs: Understanding Your Test Results: Key Insights for Multiple Myeloma Patients
Wie funktioniert die CAR-T-Zelltherapie
